Andy Mitzen

Andy Mitzen has extensive work experience in various leadership roles in the healthcare industry. Andy currently serves as the Chief Development Officer at AQUA Dermatology since September 2021. Prior to this, they were the Vice President of Business Development at US Renal Care from August 2019 to September 2021. From June 2016 to August 2019, Andy was the Chief Development Officer at QualDerm Partners. Andy also held the position of Executive Vice President of Business Development at Liberty Dialysis LLC from 2005 to 2015. Additionally, they served as the Director of Global Sales and Marketing at Baxter Capital Corporation from 2003 to 2005.

Andy Mitzen obtained their Master of Business Administration (MBA) in International Business from Lake Forest Graduate School of Management in 1995. Prior to that, they completed their Bachelor of Science (B.S.) in Biology with a minor in Chemistry at Loyola University Chicago.